Cite
HARVARD Citation
Li, W. et al. (2021). Cost‐effectiveness of icotinib versus whole‐brain irradiation with or without chemotherapy in EGFR‐mutant NSCLC patients with brain metastases. Asia-Pacific journal of clinical oncology. 17 (2), pp. e40-e47. [Online].